NORTHERN ADJUVANTS
LIVE

Serial Number

79407682

Owner

Evonik Operations GmbH

Attorney

Scott D. Woldow

Filing Date

Jul 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NORTHERN ADJUVANTS Trademark

Serial Number: 79407682 • Registration: 7943132

NORTHERN ADJUVANTS is a trademark filed by Evonik Operations GmbH on July 23, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Evonik Operations GmbH (8 trademarks)

Rellinghauser Str. 1-11

Entity Type: 16

Trademark Details

Filing Date

July 23, 2024

Registration Date

September 16, 2025

Published for Opposition

July 29, 2025

Goods & Services

Scientific and technological services, namely, scientific research, analysis and testing in the field of medical, veterinary, pharmaceutical, nutrition, and dietary products; product research and design relating thereto; industrial analysis and research services in the field of scientific chemicals and chemistry; design and development of computer hardware and software; technological research in the field of manufacturing, namely, technical consultancy in the field of the manufacture of chemical, pharmaceutical and veterinary preparations using chemical and pharmaceutical polymers; technical product development consultancy in the field of the use of biodegradable polymers for medical applications; quality control for others and material testing; expert opinion relating to technology, namely, technology consultation in the field of scientific research; materials testing and analysis; chemistry services, namely, professional consulting services and advice about agricultural chemistry, research in the field of chemistry and chemistry consultation; engineering services, engineering design services and chemical engineering services; engineering design services; bacteriological or chemical laboratory research services; physics research.

Treatment of materials, namely processing of chemical and pharmaceutical polymers for the manufacture of chemical, pharmaceutical and veterinary preparations; custom manufacture of chemical, pharmaceutical and veterinary products by means of microencapsulating techniques for others; treatment of materials, namely processing of biodegradable polymers for medical applications, in particular tissue replacement, bone formation and bone fixation as well as for the manufacture of chemical, pharmaceutical and veterinary preparations; treatment of materials, namely processing of chemical and pharmaceutical preparations for the controlled release of active ingredients in chemical, pharmaceutical and veterinary preparations; treatment of materials, namely processing of chemical and pharmaceutical preparations used for surgical, medical, dental and veterinary apparatus and instruments as well as diagnostic apparatus for medical use and apparatus for use in medical analysis; treatment of materials, namely processing of biodegradable polymers for the manufacture of artificial limbs, artificial implants, stents, syringes for medical purposes, catheter, cannula, acupuncture needles, suture needles, artificial limbs, eyes and teeth, medical guidewires, orthopedic articles, suture materials.

Pharmaceutical and veterinary preparations, namely, adjuvants for medical and veterinary purposes; adjuvants for medical purposes; Drug delivery agents in the form of coatings, lacquers and glazes: Drug delivery agents in the form of coatings, lacquers and glazes that facilitate the delivery of pharmaceutical preparations and veterinary preparations as well as for dietetic substances; cellulose esters for pharmaceutical purposes; diagnostic preparations for medical purposes; capsules for medical purposes, sold empty for pharmaceuticals; Pharmaceutical and veterinary preparations, namely, Diagnostic media for bacteriological cultures, Diagnostic biomarker reagents for medical purposes, Diagnostic reagents and contrast media for medical use; dietetic preparations adapted for medical purposes and nutritional supplements; dietetic substances adapted for medical use, namely, Dietetic preparations adapted for medical purposes, Dietetic foods adapted for medical use

Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry with exception of manures, except fungicides, herbicides, insecticides and parasiticides; chemical auxiliaries and intermediate products for the manufacture of pharmaceutical and cosmetic products; unprocessed artificial resins, unprocessed plastics; unprocessed artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products; unprocessed biodegradable polymers for medical and pharmaceutical use; unprocessed acrylic polymers for medical and pharmaceutical use; polymethyl methacrylate in the nature of unprocessed polymethyl methacrylate resins; lactic acid, namely, lactides for industrial purposes, lactides for use in pharmaceuticals, lactides for use in manufacture, lactides for use in the manufacture of pharmaceutical products; glycol, namely, glycolides for industrial purposes, glycolides for use in pharmaceuticals, glycolides for use in manufacture, glycolides for use in the manufacture of pharmaceutical products; industrial chemicals, namely, dioxanones; trimethylene carbonates; industrial chemicals, namely, caprolactones; chemical substances for preserving foodstuffs; adhesives used in industry.

Medical services; veterinary services; consultancy and information services in the field of manufacture of pharmaceuticals, namely relating to pharmaceutical compounding services.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 16, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 9, 2026 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 28, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 28, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 23, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 23, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 16, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 16, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 11, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 11, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 23, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 22, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2024 REPR